The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

Familial cerebral cavernous malformation

Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM) CCM Blood Biomarker Validation Study The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 Biomarkers of CASH CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina. Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins Modifiers of Disease Severity in Cerebral Cavernous Malformations Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation